tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Immunoblastic Lymphadenopathy D007119 2 associated lipids
Ileal Neoplasms D007078 2 associated lipids
Hypothermia D007035 19 associated lipids
Hypotension D007022 41 associated lipids
Hypoglycemia D007003 13 associated lipids
Hypertension, Renal D006977 9 associated lipids
Hypertension, Portal D006975 12 associated lipids
Hypertension D006973 115 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Hypersensitivity D006967 22 associated lipids
Hyperparathyroidism, Secondary D006962 4 associated lipids
Hyperlipidemias D006949 73 associated lipids
Hyperkalemia D006947 3 associated lipids
Hyperglycemia D006943 21 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Hypercalcemia D006934 13 associated lipids
Hyperbilirubinemia D006932 11 associated lipids
Hyperalgesia D006930 42 associated lipids
Hydronephrosis D006869 4 associated lipids
Deltaretrovirus Infections D006800 1 associated lipids
HIV Seropositivity D006679 15 associated lipids
Herpesviridae Infections D006566 4 associated lipids
Herpes Labialis D006560 1 associated lipids
Hernia, Ventral D006555 1 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hepatolenticular Degeneration D006527 3 associated lipids
Hepatitis C D006526 7 associated lipids
Hepatitis, Viral, Animal D006524 4 associated lipids
Hepatic Veno-Occlusive Disease D006504 1 associated lipids
Budd-Chiari Syndrome D006502 1 associated lipids
Hemorrhage D006470 15 associated lipids
Hemophilia A D006467 10 associated lipids
Hemolytic-Uremic Syndrome D006463 2 associated lipids
Hemolysis D006461 131 associated lipids
Hematuria D006417 13 associated lipids
Hematoma D006406 5 associated lipids
Hematologic Diseases D006402 3 associated lipids
Heart Injuries D006335 6 associated lipids
Heart Failure D006333 36 associated lipids
Cardiomegaly D006332 31 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Hearing Loss, Noise-Induced D006317 4 associated lipids
Hearing Loss, Bilateral D006312 1 associated lipids
Headache D006261 4 associated lipids
Hand Injuries D006230 1 associated lipids
Hand Dermatoses D006229 5 associated lipids
Hallucinations D006212 4 associated lipids
Gynecomastia D006177 6 associated lipids
Graves Disease D006111 6 associated lipids
Granuloma, Giant Cell D006101 7 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Gout D006073 4 associated lipids
Glycosuria D006029 10 associated lipids
Glomerulosclerosis, Focal Segmental D005923 4 associated lipids
Glomerulonephritis D005921 35 associated lipids
Gliosis D005911 6 associated lipids
Glioma D005910 112 associated lipids
Gingivitis D005891 3 associated lipids
Gingival Hyperplasia D005885 3 associated lipids
Castleman Disease D005871 3 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Gastrointestinal Diseases D005767 20 associated lipids
Gastroenteritis D005759 4 associated lipids
Fractures, Spontaneous D005598 4 associated lipids
Fox-Fordyce Disease D005588 2 associated lipids
Foot Dermatoses D005533 3 associated lipids
Foot Deformities, Acquired D005531 2 associated lipids
Food Hypersensitivity D005512 7 associated lipids
Folliculitis D005499 7 associated lipids
Fistula D005402 8 associated lipids
Fibrosis D005355 23 associated lipids
Fever D005334 35 associated lipids
Fetal Hypoxia D005311 3 associated lipids
Femur Head Necrosis D005271 5 associated lipids
Fatty Liver D005234 48 associated lipids
Fatigue D005221 10 associated lipids
Facial Neoplasms D005153 3 associated lipids
Facial Dermatoses D005148 7 associated lipids
Eye Diseases D005128 12 associated lipids
Exanthema D005076 11 associated lipids
Esophageal Perforation D004939 1 associated lipids
Erythroplasia D004919 1 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Erythema Nodosum D004893 5 associated lipids
Erythema D004890 22 associated lipids
Epilepsy, Temporal Lobe D004833 4 associated lipids
Epididymitis D004823 1 associated lipids
Epidermolysis Bullosa D004820 3 associated lipids
Enterobacteriaceae Infections D004756 5 associated lipids
Endomyocardial Fibrosis D004719 4 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Encephalitis D004660 15 associated lipids
Edema D004487 152 associated lipids
Eczema D004485 4 associated lipids
Ecthyma, Contagious D004474 1 associated lipids
Echinostomiasis D004451 1 associated lipids
Earache D004433 2 associated lipids
Dyspnea D004417 10 associated lipids
Dysplastic Nevus Syndrome D004416 1 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Fischer L et al. Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study. 2015 Transplantation pmid:26151607
Spolidorio LC et al. The long-term administration of calcineurin inhibitors decreases antioxidant enzyme activity in the rat parotid and submandibular salivary glands. 2015 Life Sci. pmid:26006038
Ali H et al. Mycophenolate mofetil-based salvage as acute GVHD prophylaxis after early discontinuation of tacrolimus and/or sirolimus. 2015 Bone Marrow Transplant. pmid:25365064
Li H et al. Resistance reversal induced by a combination of fluconazole and tacrolimus (FK506) in Candida glabrata. 2015 J. Med. Microbiol. pmid:25355935
Gallon L et al. Cellular and molecular immune profiles in renal transplant recipients after conversion from tacrolimus to sirolimus. 2015 Kidney Int. pmid:25354238
Pamuk F et al. Evaluation of gingival alterations in rats medicated with cyclosporine A, tacrolimus and sirolimus: a stereological study. 2015 J. Periodont. Res. pmid:25399832
Koreth J et al. A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial. 2015 Biol. Blood Marrow Transplant. pmid:26055298
Sikma MA et al. Pharmacokinetics and Toxicity of Tacrolimus Early After Heart and Lung Transplantation. 2015 Am. J. Transplant. pmid:26053114
Rozman Peterka T et al. Solid state compatibility study and characterization of a novel degradation product of tacrolimus in formulation. 2015 J Pharm Biomed Anal pmid:25804434
Pardi C and Oltean M An unusual case of red blood cell immunisation following liver transplantation. 2015 Blood Transfus pmid:26057497
Chen YB et al. Phase II Trial of Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma. 2015 Biol. Blood Marrow Transplant. pmid:26009261
Ribero S et al. Efficacy of topical tacrolimus for oral lichen planus: real-life experience in a retrospective cohort of patients with a review of the literature. 2015 J Eur Acad Dermatol Venereol pmid:25308924
Revollo J Update on the clinical utility of once-daily tacrolimus in the management of transplantation. 2015 Drug Des Devel Ther pmid:26005334
Qasim W et al. Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient. 2015 J. Hepatol. pmid:25308176
Cortes X et al. Successful use of infliximab and tacrolimus in a patient with Crohn's disease. 2015 Int J Clin Pharmacol Ther pmid:25997551
Takahashi N et al. Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use. 2015 Rheumatol. Int. pmid:25991396
Chan TM Treatment of severe lupus nephritis: the new horizon. 2015 Nat Rev Nephrol pmid:25421826
Brännström M et al. Livebirth after uterus transplantation. 2015 Lancet pmid:25301505
de Weerd AE et al. ABO-incompatible kidney transplant recipients have a higher bleeding risk after antigen-specific immunoadsorption. 2015 Transpl. Int. pmid:25070762
Fussner LA et al. Cardiovascular disease after liver transplantation: When, What, and Who Is at Risk. 2015 Liver Transpl. pmid:25880971
Abuabara K et al. Atopic dermatitis disease control and age: A cohort study. 2015 J. Allergy Clin. Immunol. pmid:25935107
Clark SL et al. Making every drop count for pediatric kidney transplant patients. 2015 Hosp Pediatr pmid:25934814
de Sandes-Freitas TV et al. Subclinical Lesions and Donor-Specific Antibodies in Kidney Transplant Recipients Receiving Tacrolimus-Based Immunosuppressive Regimen Followed by Early Conversion to Sirolimus. 2015 Transplantation pmid:25929604
Cheng S and Rodier F Manipulating senescence in health and disease: emerging tools. 2015 Cell Cycle pmid:25928330
Hricik DE et al. Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients. 2015 J. Am. Soc. Nephrol. pmid:25925687
Matas AJ and Gaston RS Moving Beyond Minimization Trials in Kidney Transplantation. 2015 J. Am. Soc. Nephrol. pmid:25925686
Hiraoka S et al. The earliest trough concentration predicts the dose of tacrolimus required for remission induction therapy in ulcerative colitis patients. 2015 BMC Gastroenterol pmid:25925267
Falloon K et al. Characterization of the FKBP12-Encoding Genes in Aspergillus fumigatus. 2015 PLoS ONE pmid:26366742
Goldthorpe H et al. Occlusive lung arterial lesions in endothelial-targeted, fas-induced apoptosis transgenic mice. 2015 Am. J. Respir. Cell Mol. Biol. pmid:25879383
Chapron B et al. Reversible, time-dependent inhibition of CYP3A-mediated metabolism of midazolam and tacrolimus by telaprevir in human liver microsomes. 2015 J Pharm Pharm Sci pmid:25877445
Nashan B et al. Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial. 2015 Trials pmid:25873064
Ramachandran R et al. Chronic nephrotoxicity limits successful use of Tacrolimus in the management of adult steroid-dependent minimal change disease. 2015 Nephrology (Carlton) pmid:25872662
Shahraki M et al. Influence of Tacrolimus (FK506) on Nerve Regeneration Using Allografts: A Rat Sciatic Nerve Model. 2015 J. Oral Maxillofac. Surg. pmid:25869987
Zijlstra LE et al. [Heart transplantation in the 21st century in Netherlands: improved survival in the last decade]. 2015 Ned Tijdschr Geneeskd pmid:26648576
Zhu L et al. Effects of CYP3A5 genotypes, ABCB1 C3435T and G2677T/A polymorphism on pharmacokinetics of Tacrolimus in Chinese adult liver transplant patients. 2015 Xenobiotica pmid:25869250
Söderlund C and Rådegran G Immunosuppressive therapies after heart transplantation--The balance between under- and over-immunosuppression. 2015 Transplant Rev (Orlando) pmid:25812489
Dastgheib L et al. Assessment of the adjuvant effect of tacrolimus in the management of pemphigus vulgaris: A randomized controlled trial. 2015 J Dermatolog Treat pmid:24552352
Rodríguez-Rodríguez AE et al. Glucose homeostasis changes and pancreatic β-cell proliferation after switching to cyclosporin in tacrolimus-induced diabetes mellitus. 2015 Nefrologia pmid:26299169
Dave V et al. Managing psychosis in a renal transplant recipient with bipolar affective disorder and allograft rejection. 2015 Nephrology (Carlton) pmid:25807849
Hlavaty KA et al. Cellular and molecular targeting for nanotherapeutics in transplantation tolerance. 2015 Clin. Immunol. pmid:25805659
Halvorsen JA and Aasebø W Oral tacrolimus treatment of pruritus in prurigo nodularis. 2015 Acta Derm. Venereol. pmid:25804254
La Placa M et al. Disfiguring papular sarcoidosis of the face: dramatic improvement with pimecrolimus. 2015 J Eur Acad Dermatol Venereol pmid:25073484
Rahman Z et al. Comparison of X-ray powder diffraction and solid-state nuclear magnetic resonance in estimating crystalline fraction of tacrolimus in sustained-release amorphous solid dispersion and development of discriminating dissolution method. 2015 J Pharm Sci pmid:25753829
Garritsen FM et al. Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres. 2015 J Eur Acad Dermatol Venereol pmid:25752497
Qian G et al. Successful treatment of recalcitrant granulomatous rosacea with oral thalidomide and topical pimecrolimus. 2015 J. Dermatol. pmid:25753523
Pennington CA et al. Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients. 2015 Pharmacotherapy pmid:26234282
Zhu L et al. Adrenergic stimulation sensitizes TRPV1 through upregulation of cystathionine β-synthetase in a rat model of visceral hypersensitivity. 2015 Sci Rep pmid:26527188
Wu D et al. BK Virus-Associated Nephropathy with Plasma Cell-Rich Infiltrates Treated by Bortezomib-Based Regimen. 2015 Exp Clin Transplant pmid:25748726
Jo GA et al. Isolation and characterization of a 17-kDa FKBP-type peptidyl-prolyl cis/trans isomerase from Vibrio anguillarum. 2015 Protein Expr. Purif. pmid:25747528
Tachibana T et al. Successful Engraftment and Durable Graft-versus-host Disease Control with Haploidentical Peripheral Blood and a Short-term Conditioning Regimen for Primary Graft Failure. 2015 Intern. Med. pmid:26521905
Liu J et al. Adherence to Immunosuppressive Medication in Renal Transplant Recipients From Follow-up Outpatient in China: Association of 2 Different Measurement Methods. 2015 Clin Ther pmid:26519232
Guerra Júnior AA et al. Cyclosporine versus tacrolimus: cost-effectiveness analysis for renal transplantation in Brazil. 2015 Rev Saude Publica pmid:25741648
Margolis DJ et al. Association Between Malignancy and Topical Use of Pimecrolimus. 2015 JAMA Dermatol pmid:25692459
Shuker N et al. Intra-patient variability in tacrolimus exposure: causes, consequences for clinical management. 2015 Transplant Rev (Orlando) pmid:25687818
Fan DM et al. Successful ABO-incompatible living-related intestinal transplantation: a 2-year follow-up. 2015 Am. J. Transplant. pmid:25808777
Kawakami K et al. Effects of oral tacrolimus as a rapid induction therapy in ulcerative colitis. 2015 World J. Gastroenterol. pmid:25684955
Al Gain M et al. [Sirolimus-induced lymphedema in a kidney-transplant recipient: Partial recovery after changeover to tacrolimus]. 2015 Ann Dermatol Venereol pmid:25683011
Ikeya K et al. Tacrolimus for remission induction in ulcerative colitis: Mayo endoscopic subscore 0 and 1 predict long-term prognosis. 2015 Dig Liver Dis pmid:25682993
Zhao L et al. Bovine serum albumin nanoparticles for delivery of tacrolimus to reduce its kidney uptake and functional nephrotoxicity. 2015 Int J Pharm pmid:25681723
Matsushima M et al. [A case of anti-PL7 antibody positive myositis and a clinical and pathological review of the anti-synthetase syndrome]. 2015 Rinsho Shinkeigaku pmid:26458569
Kim S et al. Reduction of increased calcineurin activity rescues impaired homeostatic synaptic plasticity in presenilin 1 M146V mutant. 2015 Neurobiol. Aging pmid:26455952
Fukuta T et al. Treatment of stroke with liposomal neuroprotective agents under cerebral ischemia conditions. 2015 Eur J Pharm Biopharm pmid:26455340
Buendía JA et al. Combinational Effect of CYP3A5 and MDR-1 Polymorphisms on Tacrolimus Pharmacokinetics in Liver Transplant Patients. 2015 Exp Clin Transplant pmid:26450467
Almeida-Corrêa S et al. Calcineurin inhibition blocks within-, but not between-session fear extinction in mice. 2015 Learn. Mem. pmid:25691516
Leneghan D and Bell A Immunophilin-protein interactions in Plasmodium falciparum. 2015 Parasitology pmid:26156578
Luo X et al. Evaluation of 6β-Hydroxycortisol and 6β-Hydroxycortisone as Biomarkers for Cytochrome P450 3A Activity: Insight into Their Predictive Value for Estimating Oral Immunosuppressant Metabolism. 2015 J Pharm Sci pmid:26150050
Herbst S et al. Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus. 2015 EMBO Mol Med pmid:25637383
Cuellar-Rodriguez J et al. Matched related and unrelated donor hematopoietic stem cell transplantation for DOCK8 deficiency. 2015 Biol. Blood Marrow Transplant. pmid:25636378
Schoettler M et al. Treatment and outcomes of immune cytopenias following solid organ transplant in children. 2015 Pediatr Blood Cancer pmid:25308853
Joneja U and Uppal G Pseudo-Pelger-Huët anomaly in a patient on tacrolimus. 2015 Blood pmid:26371350
Chung H et al. Renal transplantation: better fat than thin. 2015 J. Surg. Res. pmid:25634827
Ustundag UV et al. The effects of tacrolimus on the activity and expression of tissue factor in the rat ovary with ischemia-reperfusion induced injury. 2015 Reprod Biol pmid:26370456
Mok CC Mycophenolate mofetil for lupus nephritis: an update. 2015 Expert Rev Clin Immunol pmid:26364748
Satake K et al. Olopatadine hydrochloride suppresses hot flashes induced by topical treatment with tacrolimus ointment in rats. 2015 Eur. J. Pharmacol. pmid:26362749
Gao L and Sun Y In vitro interactions of antifungal agents and tacrolimus against Aspergillus biofilms. 2015 Antimicrob. Agents Chemother. pmid:26303797
Kawahara T et al. Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1. 2015 Oncotarget pmid:25638160
Kita A et al. Imp2, the PSTPIP homolog in fission yeast, affects sensitivity to the immunosuppressant FK506 and membrane trafficking in fission yeast. 2015 Biochem. Biophys. Res. Commun. pmid:25580011
Cortina G et al. De novo tacrolimus-induced thrombotic microangiopathy in the early stage after renal transplantation successfully treated with conversion to everolimus. 2015 Pediatr. Nephrol. pmid:25577332
Pape E et al. Management of Tacrolimus-Telaprevir Drug-Drug Interaction in a Liver Transplant Patient With Hepatitis C Virus: Practical Considerations. 2015 Transplantation pmid:26308424
Iwamoto T et al. Effect of Genetic Polymorphism of CYP3A5 and CYP2C19 and Concomitant Use of Voriconazole on Blood Tacrolimus Concentration in Patients Receiving Hematopoietic Stem Cell Transplantation. 2015 Ther Drug Monit pmid:25565672
Ruiz J et al. Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation. 2015 Int J Mol Sci pmid:26307985
Yao X et al. Limited Sampling Strategy for Mycophenolic Acid in Chinese Kidney Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium and Tacrolimus During the Early Posttransplantation Phase. 2015 Ther Drug Monit pmid:25565669
Nelson R et al. Sirolimus, tacrolimus and antithymocyte globulin as GVHD prophylaxis in HLA-mismatched unrelated donor hematopoietic cell transplantation: a single institution experience. 2015 Bone Marrow Transplant. pmid:26301969
Lemaitre F et al. Pharmacokinetics and pharmacodynamics of tacrolimus in liver transplant recipients: inside the white blood cells. 2015 Clin. Biochem. pmid:25562187
Reddy YN et al. Is there a genetic predisposition to new-onset diabetes after kidney transplantation? 2015 Saudi J Kidney Dis Transpl pmid:26586047
Bauters T et al. Practical considerations in the use of intravenous tacrolimus in hematopoietic stem cell transplantation patients. 2015 J Oncol Pharm Pract pmid:24748582
Yu Y et al. Investigation into the interchangeability of generic formulations using immunosuppressants and a broad selection of medicines. 2015 Eur. J. Clin. Pharmacol. pmid:26062932
Millner L et al. A clinical approach to solving discrepancies in therapeutic drug monitoring results for patients on sirolimus or tacrolimus: Towards personalized medicine, immunosuppression and pharmacogenomics. 2015 Clin. Chim. Acta pmid:26232156
Tornatore KM et al. Influence of sex and race on mycophenolic acid pharmacokinetics in stable African American and Caucasian renal transplant recipients. 2015 Clin Pharmacokinet pmid:25511793
Li JL et al. Interactive effects of CYP3A4, CYP3A5, MDR1 and NR1I2 polymorphisms on tracrolimus trough concentrations in early postrenal transplant recipients. 2015 Pharmacogenomics pmid:26228923
Zhu LQ et al. Posterior reversible encephalopathy syndrome and graft-versus-host disease after liver transplantation: a case report and review of the literature. 2015 Int J Clin Pharmacol Ther pmid:26227100
Lu YX et al. A population pharmacokinetic study of tacrolimus in healthy Chinese volunteers and liver transplant patients. 2015 Acta Pharmacol. Sin. pmid:25500866
Zhang JJ et al. The genetic polymorphisms of POR*28 and CYP3A5*3 significantly influence the pharmacokinetics of tacrolimus in Chinese renal transplant recipients. 2015 Int J Clin Pharmacol Ther pmid:26227094
Roberts WK et al. A destructive feedback loop mediated by CXCL10 in central nervous system inflammatory disease. 2015 Ann. Neurol. pmid:26224283
Kloster-Jensen K et al. Intracellular sirolimus concentration is reduced by tacrolimus in human pancreatic islets in vitro. 2015 Transpl. Int. pmid:26046470
Peake RW et al. Multicenter evaluation of the thermo scientific prelude for measurement of immunosuppressant drugs using sample preparation liquid chromatography-tandem mass spectrometry. 2015 Ther Drug Monit pmid:25072947
Mettang T and Kremer AE Uremic pruritus. 2015 Kidney Int. pmid:24402092
Allison SJ Lupus nephritis: Multitarget induction therapy for LN. 2015 Nat Rev Nephrol pmid:25421833
Takeuchi S et al. Pruritus of patients with atopic dermatitis in daily life and their experience of therapeutic effects: results of a web-based questionnaire survey. 2015 Br. J. Dermatol. pmid:25421804
Lancia P et al. Choosing the right dose of tacrolimus. 2015 Arch. Dis. Child. pmid:25416736